These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38775304)

  • 1. Population pharmacokinetics and dose rationale for aciclovir in term and pre-term neonates with herpes.
    D'Agate S; Ruiz Gabarre D; Della Pasqua O
    Pharmacol Res Perspect; 2024 Jun; 12(3):e1193. PubMed ID: 38775304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of oral acyclovir in neonates and in infants: a population analysis.
    Tod M; Lokiec F; Bidault R; De Bony F; Petitjean O; Aujard Y
    Antimicrob Agents Chemother; 2001 Jan; 45(1):150-7. PubMed ID: 11120958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of intravenous acyclovir in preterm and term infants.
    Sampson MR; Bloom BT; Lenfestey RW; Harper B; Kashuba AD; Anand R; Benjamin DK; Capparelli E; Cohen-Wolkowiez M; Smith PB;
    Pediatr Infect Dis J; 2014 Jan; 33(1):42-9. PubMed ID: 24346595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and pharmacokinetics of aciclovir in women following release from a silicone elastomer vaginal ring.
    Keller MJ; Malone AM; Carpenter CA; Lo Y; Huang M; Corey L; Willis R; Nguyen C; Kennedy S; Gunawardana M; Guerrero D; Moss JA; Baum MM; Smith TJ; Herold BC
    J Antimicrob Chemother; 2012 Aug; 67(8):2005-12. PubMed ID: 22556381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral agents for treatment of herpes simplex virus infection in neonates.
    Jones CA; Walker KS; Badawi N
    Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD004206. PubMed ID: 19588350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections.
    Perry CM; Faulds D
    Drugs; 1996 Nov; 52(5):754-72. PubMed ID: 9118821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acyclovir therapy in neonates.
    Englund JA; Fletcher CV; Balfour HH
    J Pediatr; 1991 Jul; 119(1 Pt 1):129-35. PubMed ID: 2066845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic drug monitoring of continuous-infusion acylovir for disseminated herpes simplex virus infection in a neonate receiving concurrent extracorporeal life support and continuous renal replacement therapy.
    Cies JJ; Moore WS; Miller K; Small C; Carella D; Conley S; Parker J; Shea P; Chopra A
    Pharmacotherapy; 2015 Feb; 35(2):229-33. PubMed ID: 25556960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and safety of valaciclovir in children with Epstein-Barr virus illness.
    Simon MW; Fish DN; Deeter RG
    Drugs R D; 2002; 3(6):365-73. PubMed ID: 12516939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of acyclovir in children and young people with malignancy after administration of intravenous acyclovir or oral valacyclovir.
    Zeng L; Nath CE; Blair EY; Shaw PJ; Stephen K; Earl JW; Coakley JC; McLachlan AJ
    Antimicrob Agents Chemother; 2009 Jul; 53(7):2918-27. PubMed ID: 19414579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk of CNS adverse effects of aciclovir and valaciclovir. Watch the renal function in treatment of herpes simplex and herpes zoster].
    Helldén A; Bergman U; Dwyer R; Medin C; Molanaei H; Ståhle L; Thylén P; Odar-Cederlöf I
    Lakartidningen; 2007 Jun 13-26; 104(24-25):1916-20. PubMed ID: 17674672
    [No Abstract]   [Full Text] [Related]  

  • 12. Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance.
    Anderson BJ; Allegaert K; Van den Anker JN; Cossey V; Holford NH
    Br J Clin Pharmacol; 2007 Jan; 63(1):75-84. PubMed ID: 16869817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.
    Wagstaff AJ; Faulds D; Goa KL
    Drugs; 1994 Jan; 47(1):153-205. PubMed ID: 7510619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials.
    Johnston C; Saracino M; Kuntz S; Magaret A; Selke S; Huang ML; Schiffer JT; Koelle DM; Corey L; Wald A
    Lancet; 2012 Feb; 379(9816):641-7. PubMed ID: 22225814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of neonatal herpes simplex virus infection.
    Kesson AM
    Paediatr Drugs; 2001; 3(2):81-90. PubMed ID: 11269641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes simplex virus, meningitis and encephalitis in neonates.
    Kimberlin D
    Herpes; 2004 Jun; 11 Suppl 2():65A-76A. PubMed ID: 15319092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of aciclovir in herpes simplex virus infections.
    Kesson AM
    J Paediatr Child Health; 1998 Feb; 34(1):9-13. PubMed ID: 9568933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret's.
    Tyler KL
    Herpes; 2004 Jun; 11 Suppl 2():57A-64A. PubMed ID: 15319091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent aciclovir-resistant herpes simplex in a child with Wiskott-Aldrich syndrome.
    Saijo M; Suzutani T; Murono K; Hirano Y; Itoh K
    Br J Dermatol; 1998 Aug; 139(2):311-4. PubMed ID: 9767251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.
    Ormrod D; Scott LJ; Perry CM
    Drugs; 2000 Apr; 59(4):839-63. PubMed ID: 10804039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.